Measurably Relating Treatment Effects on Disintegration and Impairmentnoun in Multiple Sclerosis Patients
To decide if treatment adequacy on backslides do empower to anticipate treatment
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
To decide if treatment adequacy on backslides do empower to anticipate treatment
Multiple sclerosis (MS) is an inflammatory disease affecting the central nervous system and leading to neurological defects. Rituximab is a medication that is administered intravenously for treating MS. The present…
There is evidence of episodic memory as one of the mostly reported complaints among Multiple Sclerosis (MS) patients with impaired cognition, while their semantic memory remains relatively intact. In this ... memory and…
Major depression and suicide are high among patients with MS. Despite the
explain some of the uncommon differentials which have similar manifestations like NMOSD. Example Multiple sclerosis (MS), Acute disseminated encephalomalitis (ADEM), Subacute combined neuro degeneration…
explain some of the uncommon differentials which have similar manifestations like NMOSD. Example Multiple sclerosis (MS), Acute disseminated encephalomalitis (ADEM), Subacute combined neuro degeneration…
Fatigue in Multiple Sclerosis [MS] is one of the most disabling symptoms having a negative impact on disability scores and on Health-Related Quality of Life [HRQOL] occurring more frequently ... severity in patients…
Multiple sclerosis (MS) is a chronic disease confined to the central nervous system (CNS). Its pathological hallmarks are neuroinflammation, de- and remyelination, neurodegeneration and astrogliosis. This…
Background: Dimethyl fumarate (DMF), an oral diseasemodifying treatment for Multiple Sclerosis (MS), displays anti-oxidative properties, thought to be via modulation of glutathione (GSH). However, to date, the effect…
real-world setting, through a retrospective analysis of data in patients with multiple sclerosis that receiving fingolimod at a single centre in Italy. Ninety patients were divided into two groups ... switching from…
between cerebral blood flow velocities and event related potential (ERP) changes in non-dementia multiple sclerosis (MS) are completely lacking. The aim of the present study was to evaluate ... mean age of 37 ± 8 years…
exact mechanisms underlying neuroinflammation and neuropathology in multiple sclerosis (MS) are still unknown, but susceptibility depends on a combination of genetic and environmental risk factors and their…
million, is considered to have a medium (5-30/100 000) prevalence rate of Multiple Sclerosis. Teriflunomide is one of two oral disease modifying agents that have been registered ... Methods: A retrospective analysis was…
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in central nervous system (CNS) characterized by demyelination as well as axonal and neuronal degeneration. Glatiramer acetate, is a mixture…
presence of periventricular lesions (PVL) on MRI scans is part of the revised McDonald multiple sclerosis (MS) diagnostic criteria. However, PVL can be found in other neurological diseases including stroke ... stroke…
Background: Multiple Sclerosis (MS) is one of the most common autoimmune diseases in adults that cause disability in patients. Different studies were conducted on the more rapid diagnosis ... current study aimed at…
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with presumed autoimmune etiology. Within the last years an important success has been achieved in understanding…
patient was treated with methylprednisolone and experienced rapid improvement. She was diagnosed with pediatric multiple sclerosis (MS) and started on interferon Ã?1a. Conclusions: Patients suffering isolated and…
Objectives: MS Patients experience lower quality of life than the general population
Background: Multiple sclerosis (MS) is the most chronic and inflammatory disorder that result in physical disability. Because of limited efficacy and adverse side effects, identifying novel therapeutic and protective…
Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS). Here, we have explored a novel use of glyceryl tribenzoate (GTB), a flavoring ingredient ... Oral feeding…
Introduction: Multiple sclerosis (MS) is a socially important disease, with a high level of acquired disability in a relatively young population. Motor weakness, spasticity, balance and coordination dysfunctions provoke…
Introduction: Multiple sclerosis (MS) is a socially important disease, with a high level of acquired disability in a relatively young population. Motor weakness, spasticity, balance and coordination dysfunctions provoke…
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system, characterized by inflammation, demyelination, and axonal damage. Its exact cause remains elusive, but a combination of genetic…
Statement: Multiple Sclerosis (MS) often leads to significant cognitive impairment, affecting attention, memory, and executive function. Enhancing neuroplasticity through cognitive rehabilitation is a promising…
For authors and organisers
Find the right journal for your paper and submit your manuscript.